Abstract
A sirolimus-eluting bioresorbable magnesium scaffold (Mg-BRS) has demonstrated encouraging clinical outcomes in selected patients with stable coronary artery disease. However, very little is known about the performance of this novel device in patients suffering for an acute myocardial infarction (
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
